NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws.On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN). The company reported that ...
ACCESSWIRE
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance. The Company is now expecting ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zions Bancorporation, National Association ("Zions Bancorporation, National Association") (NASDAQ:ZION) concerning possible violations of federal securities laws.Bloomberg published a report on October 16, 2025, titled, "Zions, Western Alliance Banks Disclose Bad Loans Tied to Alleged Fraud." The article revealed that Zions and another ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") (NYSE:ATKR). Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ATKR. Investigation ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lineage, Inc. ("Lineage" or "the Company") (NASDAQ:LINE). Investors who purchased Lineage securities prior to July 25, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LINE. Investigation DetailsThe investigation ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PCRX. Investigation DetailsThe ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG). Investors who purchased PepGen securities prior to March 7, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PEPG. Investigation DetailsThe investigation ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST). Investors who purchased RxSight securities prior to November 7, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RXST. Investigation DetailsThe ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI). Investors who purchased MGP Ingredients securities prior to May 4, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DoubleVerify Holdings, Inc. ("DoubleVerify" or "the Company") (NYSE:DV). Investors who purchased DoubleVerify securities prior to November 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DV. Investigation ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Palantir Technologies, Inc. ("Palantir" or "the Company") (NASDAQ:PLTR). Investors who purchased Palantir securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PLTR. Investigation DetailsOn October 3, 2025, Reuters published ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ:LRMR). Investors who purchased Larimar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LRMR. Investigation DetailsOn September 29, 2025, Larimar announced data from an ongoing ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: ...
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ZBIO.
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. ("Sable" or "the Company") (NYSE:SOC). Investors who purchased Sable securities prior to May 21, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SOC. Investigation DetailsThe investigation ...
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities prior to July 3, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FTRE. Investigation DetailsThe ...